DMD-Null mice exhibit severe muscle weakness, impaired regeneration, and deficient satellite cell function

Area of Science:

• Biomedical research
• Genetics and genomics
• Muscle physiology

Background:

• Duchenne muscular dystrophy (DMD) is a fatal X-linked disease with no cure.
• The mdx mouse model, while common, displays a milder phenotype than human DMD due to residual dystrophin isoforms.
• A need exists for more accurate animal models to study DMD pathogenesis and test therapies.

Purpose of the Study:

• To functionally characterize DMD-Null mice, which completely lack dystrophin.
• To compare the DMD-Null mouse phenotype to the established mdx mouse model.
• To evaluate DMD-Null mice as a model for DMD research and therapeutic testing.

Main Methods:

• Comprehensive functional assessment of DMD-Null mice.
• Phenotypic comparison between DMD-Null and mdx mice.
• Analysis of skeletal muscle, exercise tolerance, muscle regeneration, satellite cell function, and gene expression.

Main Results:

• DMD-Null mice exhibit a more severe skeletal muscle phenotype, profound weakness, and decreased exercise tolerance compared to mdx mice.
• Muscle regeneration is impaired in DMD-Null mice, with deficits in satellite cell proliferation and myogenic differentiation.
• Utrophin upregulation is observed in both DMD-Null and mdx mice, but regenerative gene programs are downregulated in DMD-Null mice.

Conclusions:

• DMD-Null mice present a more severe and relevant model for Duchenne muscular dystrophy than mdx mice.
• Short dystrophin isoforms may play a role in muscle stem cell function.
• DMD-Null mice are valuable for investigating DMD pathogenesis and evaluating therapies targeting satellite cell health and regeneration.